Mostrando 3 resultados de: 3
Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting
ReviewAbstract: Cancer immunotherapy is proposed to eradicate tumors by stimulating host anti-tumor immunity throughPalabras claves:Cancer immunotherapy, cancer vaccine, Dendritic cells, Nanoplatforms, NanovaccinesAutores:Achmad H., Andrés Alexis Ramírez-Coronel, Elena Stanislavovna M., Gabr G.A., Gupta J., Hamoud Alshahrani S., Mohammed Al-Taee M., Saleh Ibrahim Y., Sawitri W., Setia Budi H., Turki Jalil A., Waheed Riaz M.Fuentes:scopus“To be or not to Be”: Regulatory T cells in melanoma
ReviewAbstract: In spite of progresses in the therapy of different malignancies, melanoma still remains as one of lePalabras claves:Cáncer, immunotherapy, melanoma, Treatment, Treg cellAutores:AL-Ghamdi H.S., Alghamdi M.A., Almulla A.F., Amin A.H., Andrés Alexis Ramírez-Coronel, Gabr G.A., Ibrahim Y.S., Jawhar Z.H., Raheem Lateef Al-Awsi G., Shbeer A.M.Fuentes:scopusThe functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer
ReviewAbstract: Currently, cancer ranks as the second leading cause of death worldwide, and at the same time, the buPalabras claves:Cáncer, Chemoresistance, signal transduction, TRIB3Autores:Alameri A.A., Aljoborae F.F.M., Andrés Alexis Ramírez-Coronel, Ansari S.A., Arif A., Gabr G.A., Jabbar H.S., Karampoor S., Mirzaei R., Qasim M.T., Sakr H.I., Tariq U.B.Fuentes:scopus